Trending:
News
-
20 June 2018
FDA clears Arcuro’s SuperBall meniscus repair system
The US Food and Drug Administration (FDA) has awarded regulatory clearance for the Arcuro Medical’s (Arcuro) SuperBall meniscus repair system.
-
20 June 2018
Neural Analytics secures CE Mark for robotic ultrasound system
US-based medical robotics company Neural Analytics has received a CE Mark for its new robotic ultrasound solution called NeuralBot System.
-
19 June 2018
First trial of robot-assisted retinal surgery is successful
Oxford University researchers have completed the first successful trial of robot-assisted retinal surgery.
-
19 June 2018
SOPHiA GENETICS acquires French firm Interactive Biosoftware
Data-driven medicine company SOPHiA GENETICS has completed the acquisition of French tech company Interactive Biosoftware (IBS).
-
19 June 2018
Thermo Fisher launches Ion AmpliSeq technology for oncology research
Thermo Fisher Scientific has launched its new library preparation innovation, Ion AmpliSeq HD technology, for targeted next-generation sequencing (NGS) oncology and genetic research applications.
-
19 June 2018
New 3D imaging technique can bolster arthritis treatment
A team of professionals led by the University of Cambridge has developed a new algorithm to monitor the joints of arthritis patients and track small changes to enable a better...
-
18 June 2018
New blood test can better predict heart attack risk
Researchers from the Austin Health and the University of Melbourne have developed a new blood test to improve the risk assessment of long-term heart attack or death in severe coronary artery...
-
18 June 2018
LivaNova gets US clearance for mitral annuloplasty ring
UK-based medical technology company LivaNova has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its MEMO 4D semi-rigid mitral annuloplasty ring.
-
18 June 2018
BlueWind gets approval for study design of RENOVA iStim system
Miniature wireless neurostimulation platform developer BlueWind Medical has secured approval from the US Food and Drug Administration (FDA) for study design for its RENOVA iStim system.
-
15 June 2018
Simulation tool can predict efficacy of HIV-prophylaxis
Researchers from Freie Universität Berlin have developed a mathematical simulation tool to predict the efficacy of pre and post-exposure prophylaxis (PrEP) medications, which can help to prevent HIV infection.
